Connect your AI

Pfizer PFE Emerging Markets — Property, plant and equipment, net

Other geography segments

Developed Markets

$8.18B+13.8%

Other financials

Income statement

Revenue$14.5B+5.4%

Gross profit$10.9B+0.3%

Net income$2.7B-9.4%

EPS (diluted)$0.47-9.6%

Balance sheet

Cash & equivalents$1.8B+18.8%

Total debt$64.4B+4.9%

Total equity$90.1B-0.3%

Total assets$207.62B-0.2%

Cash flow

Operating cash flow$2.6B+12.0%

CapEx$436.0M-22.7%

Free cash flow$2.2B+23.0%

Valuation

Market cap$143.91B+4.2%

Enterprise value$206.58B+4.2%

P/E11.9×—

P/S2.3×+0.1×

Profitability

Gross margin73.5%+1.2pp

Net margin15.7%—

FCF margin18%+8.8pp

Returns & leverage

Return on equity10.6%—

Debt / equity0.7×0.0×

Current ratio1.2×0.0×

Where this comes from

Reported directly by Pfizer in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Pfizer’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pfizer's emerging markets — property, plant and equipment, net.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Pfizer's emerging markets — property, plant and equipment, net?: Pfizer (PFE) reported emerging markets — property, plant and equipment, net of $1.46B in Q4 2025.